Two regions of human thyrotropin (thyroidstimulating hormone, TSH) receptor (TSHR) (residues 1244 and 308-364) were selected on the basis that they exhibit no sequence resemblance to luteinizing hormone/chorionic gonadotropin receptor. Five synthetic overlapping peptides (12-30, 24-44, 308-328, 324-344, and 339-364) were studied for their ability to bind '5Ilabeled human TSH (hTSH), its isolated a and j3 subunits, bovine TSH, ovine TSH, human luteinizing hormone, and human follicle-stimulating hormone. The human TSHR peptides 12-30 and 324-344 exhibited remarkable binding activity to human, bovine, and ovine TSH and to the /3 chain of hTSH. Lower binding activity resided in the adjacent overlapping peptides, probably due to the contribution of the shared overlap to the binding. The specificity of TSH binding to these peptides was confirmed by their inability to bind human luteinizing hormone, human follicle-stimulating hormone, and the a chain of hTSH. Thyrotropins did not bind to bovine serum albumin or to peptide controls unrelated to the TSHR system. Furthermore, the binding of hTSH to TSHR peptides 12-30 and 324-344 was almost completely (=90%) inhibited by rabbit antibodies against hTSH but not by antisera against unrelated proteins. It is concluded that the binding of TSH to its receptor involves extensive contacts and that the TSHR peptides 12-30 and 324-344 contain specific binding regions for TSH that might be either independent sites or two faces (subsites) within a large binding site.
lated a and j3 subunits, bovine TSH, ovine TSH, human luteinizing hormone, and human follicle-stimulating hormone. The human TSHR peptides 12-30 and 324-344 exhibited remarkable binding activity to human, bovine, and ovine TSH and to the /3 chain of hTSH. Lower binding activity resided in the adjacent overlapping peptides, probably due to the contribution of the shared overlap to the binding. The specificity of TSH binding to these peptides was confirmed by their inability to bind human luteinizing hormone, human follicle-stimulating hormone, and the a chain of hTSH. Thyrotropins did not bind to bovine serum albumin or to peptide controls unrelated to the TSHR system. Furthermore, the binding of hTSH to TSHR peptides 12-30 and 324-344 was almost completely (=90%) inhibited by rabbit antibodies against hTSH but not by antisera against unrelated proteins. It is concluded that the binding of TSH to its receptor involves extensive contacts and that the TSHR peptides 12-30 and 324-344 contain specific binding regions for TSH that might be either independent sites or two faces (subsites) within a large binding site.
Thyrotropin (thyroid-stimulating hormone, TSH) belongs to a family of closely related glycoprotein hormones that includes lutropin (luteinizing hormone, LH), folliclestimulating hormone (FSH), and chorionic gonadotropin (CG). The first three (TSH, LH, and FSH) are produced by the anterior pituitary, whereas CG is made in the trophoblast during pregnancy. Each of these hormones consists of two different subunits (a and /) that are not covalently linked and, in a given species, the a subunits are identical for all these hormones (1) (2) (3) (4) . Although their a subunit is unchanged, these hormones have different biological activities. TSH stimulates the thyroid gland to secrete thyroxin and triiodothyronine into the circulation, and the latter are required for proper metabolism, differentiation, and development of tissues. The major functions of LH and FSH are in reproductive physiology, whereas CG stimulates the production ofprogesterone (2). Because they have identical a chains, the activities of these hormones are clearly determined by their / subunits. The hormones bind to specific receptors on target cells, and the activated receptor stimulates adenylate cyclase through the G protein (2, 5) . Recent molecular cloning and cDNA sequencing studies have provided the primary structures of dog TSH receptor (TSHR) (6) and human (h) TSHR (7) (8) (9) . Also, the primary structures of rat (10) and porcine (11) LH/CG receptor have been deduced from the respective cDNA sequences. Comparison of the amino acid sequences of the extracellular parts of the LH/CG and the TSH receptors revealed that these G protein-coupled receptors display an extensive sequence similarity. The consecutive peptides. The C-terminal glycine residues are not part of the hTSHR sequence, but the peptides were synthesized on a glycine resin for convenience. The peptides were prepared by solid-phase peptide synthesis on a benzyloxybenzyl alcohol resin (Vega Biotechnologies) to which 9-fluorenylmethylcarbonyl (Fmoc)-glycine had been coupled. The Na-Fmoc amino acid derivatives were obtained from Vega or from Peninsula Laboratories. The side-chain protecting groups were as follows: aspartic and glutamic, /3-and y-tert-butyl esters, respectively; cysteine, S-tert-butyl; histidine, im-trityl; lysine, e-tert-butoxycarbonyl; serine, threonine, and tyrosine, O-tert-butyl; arginine, N0-methoxy-2,3,6-trimethylphenylsulfonyl. Removal of the Na-Fmoc group before each coupling was done by treatment of the peptide resin with 20o piperidine in dimethylformamide (DMF) for 10 min. This was followed by washing ( 
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Fmoc-group, the peptide was cleaved from the resin by treatment (2.5 hr) with 55% trifluoroacetic acid in CH2Cl2 (13) , and the solvent was removed on a rotary evaporator. The peptide was washed three times with cold ether, dissolved in water, and freeze-dried. The products were purified by chromatography on CM-Sephadex C50 or DEAESephadex A50, as appropriate (14, 15) . The peptides thus obtained were homogeneous by high-voltage paper electrophoresis and by analytical HPLC on a C18 column using a gradient of 0.1% trifluoracetic acid in water/0.1% trifluoracetic acid in acetonitrile. The amino acid compositions of the peptides were in excellent agreement with those expected from their sequences.
Binding Studies. Proteins were labeled with 1251 by the chloramine-T method (16) 
DISCUSSION
Comparison of the amino acid sequences of the extracellular domains of dog and human TSHR with those of rat and porcine LH/CG receptor revealed that these G proteincoupled receptors contain extensive regions of homology. However, the TSHR molecule contains two particular regions (residues 12-44 and 308-364) that have no homology with the LH/CG receptor. In fact, regions 18-25 and 313-364 have no counterpart in LH/CG receptor. We, therefore, reasoned that the regions specific to TSHR might be responsible for its binding to TSH. The two regions of hTSHR were thus synthesized using an overlapping peptide strategy (19) to protect against the inadvertent scission of a binding region between two consecutive peptides that might result in destruction of binding activity (19) . The overlapping peptide approach has enabled localization of protein-binding sites of diverse activities (19) (20) (21) .
The finding that the TSHR peptides 12-30 and 324-344 possessed considerable binding activity for TSH and did not bind LH or FSH confirmed that these two peptides contain specific binding regions for TSH. The specificity of TSH binding to the peptides was also indicated from their remarkable binding activity for the ,8 subunit of hTSH and complete lack of binding for its a subunit. Finally, the ability of anti-hTSH antibodies to completely inhibit the binding of hTSH to peptides 12-30 and 324-344 strongly confirmed the specificity of this binding. The small binding activity of peptide 24-44 for TSH and its j8 subunit is probably due to the 7-residue overlap it shares with peptide 12-30. Similarly, the low activities of peptides 308-323 and 339-364 are probably derived from their overlaps with peptide 324-344. Note that the overlapping peptide strategy is not designed to give the exact boundaries of binding sites but rather to localize the maximal continuous regions within which these sites would reside (19) (20) (21) . Further studies of other appropriately designed synthetic peptides spanning these areas are required to define the boundaries of the sites.
The a subunit is identical in TSH, LH, FSH, and CG of a given species. The binding site on the hormone for the receptor has been proposed to comprise parts of both the a and subunits of a given hormone (1, 2) . Our finding that the isolated /8 subunit of hTSH binds to the synthetic binding regions of hTSHR and that it does so with an affinity only slightly smaller than that of the a,8 dimeric hTSH indicates, at least in TSH, that no contact residues are contributed by the a chain to the binding site. Furthermore, the a chain may play only a minimal role in inducing the 18 chain to achieve appropriate folding that will produce the correct conformation of its binding site because a major role would have been reflected in large affinity differences between hTSH and its subunit for the peptides. The role of the a subunit is to be internalized (after binding of the P subunit to the receptor) to stimulate adenylate cyclase (1, 2) .
The two hormones hTSH and bTSH possessed comparable affinities in their binding to hTSH peptides 12-30 and 324- . 2 ). 344. There are 12 amino differences between the f subunits of hTSH and bTSH (Table 2) . Except for the substitution at position 69 (Leu -* Arg), these replacements are conservative, and they clearly do not cause significant differences in the binding properties of the two hormones. On the other hand, oTSH showed a lower binding activity to any given hTSHR peptide than that of the other two hormones. This result must be caused by the amino acid differences between the 1 subunit of oTSH and the consensus sequence for the subunit in hTSH and bTSH. The amino acid sequence of the X8 subunit of oTSH has not been determined.
Humans can mount autoimmune responses against selfhTSHR. Some autoantibodies are stimulatory and cause Graves disease, one of the most frequent causes of hyperthyroidism (23) . It is, therefore, important to determine whether the present peptides bind to anti-hTSHR autoantibodies.
We conclude that the TSH-binding regions on TSHR reside within, but may not necessarily include all of, areas 12-30 and 324-344. The two binding regions of TSHR might carry separate binding sites or might constitute different faces (subsites) within a single binding site, and each of these subsites possesses sufficient binding energy to give a fruitful complex. For example, the binding of a-neurotoxins to acetylcholine receptor involves several contact regions on the receptor (21, 24, 25) and on the neurotoxin (26) . It has recently been shown (27) that the binding regions on acetylcholine receptor form a single cavity within which the toxin fits. In addition to the main binding regions within hTSHR peptides 12-30 and 324-344, the lower activities in peptides Table 2 . Sequence differences between hTSHIB and bTSH,3 24-44, 308-328, and 339-364 may indicate a smaller contribution by these regions to the architecture of the site and its binding energy. Alternatively, the activities of these three peptides may stem from the fact that they share overlaps with the two main active regions within 12-30 and 324-344. Our results do not rule out that other parts of the receptor molecule that come in close proximity to these two regions in the three-dimensional structure might also contribute to the architecture of the site.
